Standard Lithium Ltd.
SLI NYSE Chemicals & Allied Products Financials FY2024–FY2025
What Standard Lithium Ltd. does
No business description yet.
- Legal name
- STANDARD LITHIUM LTD.
- Fiscal year ends
- December 31, 2025
- Latest annual report
- 40-F · Mar 30, 2026
- Accession · CIK
- 0001193125-26-130448
0001537137
Revenue and margins
Standard Lithium Ltd. had $1.9M of revenue in fiscal 2025.
Net income and earnings per share
Loss periods are shown in red.
Returns on capital
After-tax operating income as a share of the money invested in the business: debt plus equity, minus cash.
Cash flow
Free cash flow was — in fiscal 2025, — of revenue. Cash from operations minus capital spending.
Dividends, buybacks and share count
Standard Lithium Ltd. returned — to shareholders in fiscal 2025. The diluted share count rose 0.0%.
Balance sheet
Cash, debt and the ratios that show how comfortably Standard Lithium Ltd. can carry it.
| Fiscal year end | FY24 | FY25 |
|---|---|---|
| Cash and short-term investments | $31.2M | $152M |
| Interest coverage | — | −830.0x |
| Current ratio | 5.8x | 15.6x |
| Quick ratio | 5.8x | 15.6x |
| Total assets | $259M | $387M |
| Total liabilities | $31.4M | $32.6M |
| Shareholders' equity | $228M | $354M |
| Net debt (− = net cash) | — | — |
Insider trades
Open-market purchases and sales by officers, directors and 10% owners, from Form 4 filings. “Plan” marks trades under a pre-arranged Rule 10b5-1 plan.
Bought, 12 months
$0.0M
0 insiders
Sold, 12 months
$0.0M
0 insiders
Of sales under plans
—
$0.0M
No open-market insider trades in the last 12 months.
Piotroski F-score
Nine pass/fail tests of profitability, funding and efficiency. 8–9 is strong, 0–2 weak.
| Test | FY24 | FY25 |
|---|---|---|
| Net income is positive | ✕ | ✕ |
| Cash from operations is positive | — | — |
| Return on assets rose | — | ✕ |
| Cash from operations exceeds net income | — | — |
| Debt fell relative to assets | — | — |
| Current ratio rose | — | ✓ |
| Share count didn't rise | — | — |
| Gross margin rose | — | — |
| Revenue rose relative to assets | — | — |
| F-score | — / 1 | — / 3 |
| Accruals ratio | — | — |
| Altman Z'' | — | 12.72 |
2 years of figures
Amounts in USD. Hover a ratio’s name for its definition.
| Fiscal year | FY24 | FY25 |
|---|---|---|
| Income statement | ||
| Revenue | — | $1.9M |
| Net interest income | — | $1.9M |
| Operating income | — | −$27.4M |
| Interest expense | — | $0.0M |
| Pretax income | — | −$51.5M |
| Income tax | — | −$3.1M |
| Net income | −$1.3M | −$48.4M |
| Diluted EPS | — | −$0.23 |
| Diluted shares | — | 0.21B |
| Cash flow | ||
| Stock-based compensation | — | $6.6M |
| Balance sheet | ||
| Cash and short-term investments | $31.2M | $152M |
| Current assets | $33.3M | $158M |
| Current liabilities | $5.8M | $10.1M |
| Property and equipment, net | $1.6M | $1.0M |
| Intangible assets | $0.9M | $1.0M |
| Total assets | $259M | $387M |
| Total liabilities | $31.4M | $32.6M |
| Shareholders' equity | $228M | $354M |
| Margins | ||
| Operating margin | — | −1,474.9% |
| Net margin | — | −2,606.2% |
| Net interest share of revenue | — | 100.0% |
| Returns | ||
| Return on capital employed | — | −7.3% |
| Return on equity | −0.6% | −16.6% |
| Return on assets | −0.5% | −15.0% |
| Return on tangible equity | −0.6% | −13.7% |
| Financial health | ||
| Interest coverage | — | −830.0x |
| Current ratio | 5.8x | 15.6x |
| Quick ratio | 5.8x | 15.6x |
| Capital allocation | ||
| Stock comp / revenue | — | 354.8% |
| Quality scores | ||
| Altman Z'' | — | 12.7 |
Source: SEC EDGAR XBRL filings (CIK 0001537137). Data updated October 24, 2026. Quarterly fourth quarters are the full year minus the first nine months. For information only — not investment advice. Check the original filings before relying on any figure.